Expertise in
14
conditions

Dr. Sumana Gangi

Endocrinology | Internal Medicine
Baylor Scott & White Health
Southern Endocrinology Associates
1621 N Beltline Rd Ste, A, 
Mesquite, TX 
Offers Telehealth
29 Years of Experience

Expertise in
14
conditions
Baylor Scott & White Health
Southern Endocrinology Associates
1621 N Beltline Rd Ste, A, 
Mesquite, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sumana Gangi is an Internal Medicine specialist and an Endocrinologist in Mesquite, Texas. Dr. Gangi has been practicing medicine for over 29 years is highly rated in 14 conditions, according to our data. Her top areas of expertise are Type 2 Diabetes (T2D), Hypothyroidism, Obesity in Children, and Thyroid Storm.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Sri Venkateswara Medical College, 1997.0
Residency
Internal Medicine, Monmouth Medical Center
Specialties
Endocrinology
Internal Medicine
Licenses
Internal Medicine in NJ
Board Certifications
American Board Of Internal Medicine
Fellowships
Hepatology, UMDNJ RW Johnson Medical School
Hepatology, UMDNJNew Jersey Medical School
Endocrinology, University of Buffalo
State Univ of NY at Buffalo School of Medicine
Hospital Affiliations
Baylor Scott And White Medical Center Sunnyvale
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
EMI Health
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 28 Less Insurance Carriers -

Locations

Southern Endocrinology Associates
1621 N Beltline Rd Ste, A, Mesquite, TX 75149
Call: 469-800-2800

Additional Areas of Focus

Dr. Gangi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3437943
Study Phase: Phase 2
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

1 Total Publications

Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100).
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100).
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: July 17, 2023
Similar Doctors
Expertise in
14
conditions
Dr. Abhimanyu Garg
Endocrinology
Expertise in
14
conditions
Dr. Abhimanyu Garg
Endocrinology

University Of Texas Southwestern Medical Center At Dallas

2001 Inwood Rd, 
Dallas, TX 
 (13.4 miles away)
214-645-0538
Languages Spoken:
English
See accepted insurances

Abhimanyu Garg is an Endocrinologist in Dallas, Texas. Dr. Garg is highly rated in 14 conditions, according to our data. His top areas of expertise are Acrorenal Mandibular Syndrome, Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, and Gastric Bypass.

Expertise in
60
conditions
Dr. Oksana Hamidi
Endocrinology
Expertise in
60
conditions
Dr. Oksana Hamidi
Endocrinology

University Of Texas Southwestern Medical Center At Dallas

5323 Harry Hines Blvd, 
Dallas, TX 
 (13.1 miles away)
216-648-0600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Oksana Hamidi is an Endocrinologist in Dallas, Texas. Dr. Hamidi is highly rated in 60 conditions, according to our data. Her top areas of expertise are Pheochromocytoma, Cushing's syndrome, Adrenal Cancer, Addison's Disease, and Hormone Replacement Therapy (HRT).

Expertise in
30
conditions
Dr. Naim M. Maalouf
Endocrinology
Expertise in
30
conditions
Dr. Naim M. Maalouf
Endocrinology

Mineral Metabolism And Clinical Research Clinic

5939 Harry Hines Blvd.,, 9th Floor, Suite 925, 
Dallas, TX 
 (13.5 miles away)
214-645-2870
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Naim Maalouf is an Endocrinologist in Dallas, Texas. Dr. Maalouf is highly rated in 30 conditions, according to our data. His top areas of expertise are Milk-Alkali Syndrome, Hypercalcemia, Hyperparathyroidism, Ureteroscopy, and Parathyroidectomy. Dr. Maalouf is currently accepting new patients.

VIEW MORE Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gangi's expertise for a condition
ConditionClose
    • Distinguished
    • Type 2 Diabetes (T2D)
      Dr. Gangi is
      Distinguished
      . Learn about Type 2 Diabetes (T2D).
      See more Type 2 Diabetes (T2D) experts
    • Advanced
    • Familial Hypocalciuric Hypercalcemia Type 1
      Dr. Gangi is
      Advanced
      . Learn about Familial Hypocalciuric Hypercalcemia Type 1.
      See more Familial Hypocalciuric Hypercalcemia Type 1 experts
    • Hypercalcemia
      Dr. Gangi is
      Advanced
      . Learn about Hypercalcemia.
      See more Hypercalcemia experts
    • Hyperthyroidism
      Dr. Gangi is
      Advanced
      . Learn about Hyperthyroidism.
      See more Hyperthyroidism experts
    • Hypothyroidism
      Dr. Gangi is
      Advanced
      . Learn about Hypothyroidism.
      See more Hypothyroidism experts
    • Idiopathic Hypercalciuria
      Dr. Gangi is
      Advanced
      . Learn about Idiopathic Hypercalciuria.
      See more Idiopathic Hypercalciuria experts
    • Maturity Onset Diabetes of the Young
      Dr. Gangi is
      Advanced
      . Learn about Maturity Onset Diabetes of the Young.
      See more Maturity Onset Diabetes of the Young experts
    View All 13 Advanced Conditions
    • Experienced
    • Anaplastic Thyroid Cancer
      Dr. Gangi is
      Experienced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Autosomal Dominant Hypocalcemia
      Dr. Gangi is
      Experienced
      . Learn about Autosomal Dominant Hypocalcemia.
      See more Autosomal Dominant Hypocalcemia experts
    • Diabetic Nephropathy
      Dr. Gangi is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Diabetic Neuropathy
      Dr. Gangi is
      Experienced
      . Learn about Diabetic Neuropathy.
      See more Diabetic Neuropathy experts
    • Eunuchoidism Familial Hypogonadotropic
      Dr. Gangi is
      Experienced
      . Learn about Eunuchoidism Familial Hypogonadotropic.
      See more Eunuchoidism Familial Hypogonadotropic experts
    • Familial Isolated Hyperparathyroidism
      Dr. Gangi is
      Experienced
      . Learn about Familial Isolated Hyperparathyroidism.
      See more Familial Isolated Hyperparathyroidism experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Endocrinologists Mesquite, TX
    3. Dr. Sumana Gangi
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.